Loading…
Mohini Health & Hygiene (MHHL)₹28.20+4.83%Medical Equipment & Supplies
In the Mar 2026 quarter (consolidated), Mohini Health & Hygiene reported sales of ₹71.19 Cr, down 6.5% from Mar 2025, and net profit of −₹13.01 Cr, down 1,388.1% year on year. For the year to Mar 2026, sales were ₹144 Cr and net profit −₹17.01 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 93.31 | 101 | 98.22 | 91.28 | 76.15 | 74.14 | 71.19 |
| Expenses | 84.81 | 93.68 | 91.75 | 81.81 | 73.82 | 75.84 | 70.84 |
| Operating Profit | 6.99 | 7.98 | 5.99 | 8.99 | 1.99 | −1.99 | 0.00 |
| OPM % | 8.0% | 8.0% | 6.0% | 10.1% | 3.3% | −3.2% | −0.4% |
| Other Income | 0.00 | 4.01 | 4.01 | 1.01 | 3.01 | 3.01 | −8.01 |
| Interest | 3.01 | 2.01 | 2.01 | 1.01 | 1.99 | 1.99 | 1.99 |
| Depreciation | 2.01 | 2.01 | 2.01 | 2.01 | 3.01 | 2.01 | 2.01 |
| Profit before tax | 3.01 | 7.01 | 6.01 | 7.01 | 2.01 | −4.01 | −13.01 |
| Tax % | 45.9% | 27.9% | 10.0% | 29.9% | 35.9% | −1.0% | −1.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | −6.16 | 0.00 | −8.03 |
| Net Profit | 2.01 | 5.01 | 6.01 | 5.01 | 1.01 | −3.99 | −13.01 |
| EPS (Rs) | 0.92 | 2.84 | 3.04 | 2.68 | 0.57 | −2.18 | −6.98 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 169 | 147 | 129 | 137 | 136 | 193 | 200 | 168 | 144 |
| Expenses | 151 | 127 | 119 | 120 | 126 | 179 | 185 | 155 | 147 |
| Operating Profit | 16.98 | 19.98 | 10.99 | 17.96 | 10.98 | 12.99 | 13.97 | 11.99 | −2.99 |
| OPM % | 10.0% | 14.0% | 8.0% | 13.1% | 8.0% | 7.0% | 7.0% | 7.0% | −1.8% |
| Other Income | 1.01 | 1.01 | 6.01 | 0.00 | 7.01 | 6.01 | 8.01 | 4.01 | −6.01 |
| Interest | 6.99 | 4.99 | 4.01 | 3.99 | 4.01 | 4.01 | 4.01 | 2.99 | 3.99 |
| Depreciation | 5.02 | 5.02 | 5.02 | 5.02 | 5.02 | 4.01 | 4.02 | 5.02 | 5.02 |
| Profit before tax | 7.01 | 10.02 | 8.01 | 8.01 | 9.01 | 11.01 | 13.01 | 8.01 | −17.01 |
| Tax % | 29.9% | 27.0% | 16.0% | 25.0% | 29.9% | 35.9% | 19.9% | 30.9% | −1.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −3.99 | −7.97 |
| Net Profit | 5.01 | 7.01 | 6.99 | 6.01 | 6.01 | 7.01 | 11.01 | 6.01 | −17.01 |
| EPS (Rs) | 2.75 | 4.03 | 3.59 | 3.26 | 3.16 | 3.73 | 5.87 | 3.22 | −9.15 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 9.0% | 0.0% | 0.0% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17.97 | 17.97 | 17.96 | 17.98 | 17.98 | 17.98 | 17.97 | 17.98 | 17.98 |
| Reserves | 39.93 | 47.92 | 53.89 | 58.92 | 64.93 | 70.93 | 81.89 | 86.81 | 69.92 |
| Borrowings | 50.13 | 44.13 | 35.09 | 43.13 | 44.14 | 28.07 | 23.06 | 35.10 | 35.09 |
| Other Liabilities | 29.05 | 22.99 | 27.13 | 26.02 | 29.94 | 21.05 | 17.09 | 28.05 | 30.01 |
| Total Liabilities | 138 | 133 | 134 | 147 | 157 | 138 | 140 | 168 | 154 |
| Fixed Assets | 65.26 | 64.19 | 61.20 | 65.20 | 53.20 | 49.15 | 45.17 | 42.12 | 40.15 |
| CWIP | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.99 | 5.99 | 17.96 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 2.01 | 3.01 |
| Other Assets | 72.82 | 68.82 | 70.88 | 80.85 | 104 | 88.88 | 92.84 | 118 | 92.88 |
| Inventories | 13.87 | 18.73 | 24.02 | 30.12 | 27.16 | 24.91 | 22.25 | 36.87 | 36.30 |
| Trade receivables | 36.41 | 26.21 | 21.26 | 23.37 | 40.68 | 35.23 | 39.40 | 18.13 | 10.05 |
| Cash & equivalents | 2.42 | 0.75 | 1.38 | 1.09 | 1.10 | 1.27 | 5.02 | 14.16 | 5.50 |
| Total Assets | 138 | 133 | 134 | 147 | 157 | 138 | 140 | 168 | 154 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 3.01 | 14.03 | 16.04 | 10.02 | −5.01 | 26.06 | 14.04 | 30.06 | 9.02 |
| Cash from investing activity | −5.99 | −3.99 | −1.99 | −7.98 | 7.98 | −5.99 | −0.99 | −28.96 | −13.97 |
| Cash from financing activity | 5.02 | −12.05 | −14.05 | −3.01 | −3.01 | −20.08 | −10.03 | 8.03 | −3.01 |
| Net cash flow | 2.01 | −2.01 | 1.01 | 0.00 | 0.00 | 0.00 | 4.01 | 9.02 | −9.02 |
| Capex | 7.85 | 4.80 | 2.83 | 7.77 | 9.18 | 2.91 | 2.01 | 25.47 | 17.68 |
| Free cash flow | −2.99 | 9.95 | 13.95 | 1.99 | 2.99 | 22.91 | 11.95 | 4.98 | −7.97 |
| CFO / OP % | 23.0% | 79.0% | 151.0% | 58.0% | −30.0% | 217.0% | 121.0% | 270.0% | −337.0% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 78 | 64 | 59 | 61 | 108 | 66 | 71 | 38 | 24 |
| Inventory days | 38 | 65 | 94 | 127 | 110 | 65 | 55 | 117 | 134 |
| Days payable | 29 | 13 | 29 | 35 | 42 | 15 | 9 | 28 | 18 |
| Cash conversion cycle | 87 | 116 | 124 | 153 | 175 | 116 | 117 | 127 | 141 |
| Working capital days | 40 | 55 | 66 | 64 | 96 | 97 | 107 | 102 | 75 |
| ROCE % | — | 14.1% | 11.1% | 11.1% | 10.1% | 12.1% | 14.1% | 14.1% | −4.0% |
For the Mar 2026 quarter, Mohini Health & Hygiene reported sales of ₹71.19 Cr, down 6.5% year on year and net profit of −₹13.01 Cr, down 1,388.1% year on year. The operating margin was −0.4%.
Mohini Health & Hygiene's sales for the year to Mar 2026 were ₹144 Cr.
Net profit for the year to Mar 2026 was −₹17.01 Cr. Earnings per share over the same trailing period were ₹−9.15.
Mohini Health & Hygiene reported borrowings of ₹35.09 Cr at Mar 2026, against cash and equivalents of ₹5.50 Cr.
Cash from operations was ₹9.02 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹7.97 Cr.